Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Comparison of cap-assisted endoscopy vs. side-viewing endoscopy for examination of the major duodenal papilla: a randomized, controlled, noninferiority crossover study.

Abdelhafez M, Phillip V, Hapfelmeier A, Sturm V, Elnegouly M, Dollhopf M, Kassem A, Klare P, Nennstiel S, Schmid RM, von Delius S, Eckel F.

Endoscopy. 2019 May;51(5):419-426. doi: 10.1055/a-0662-5445. Epub 2018 Sep 10.

PMID:
30199900
2.

Mandatory criteria for the application of variability-based parameters of fluid responsiveness: a prospective study in different groups of ICU patients.

Huber W, Mayr U, Umgelter A, Franzen M, Reindl W, Schmid RM, Eckel F.

J Zhejiang Univ Sci B. 2018 Jul;19(7):515-524. doi: 10.1631/jzus.B1700243.

3.

Chemotherapy and targeted therapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials.

Eckel F, Schmid RM.

Chemotherapy. 2014;60(1):13-23. doi: 10.1159/000365781. Epub 2014 Oct 21.

PMID:
25341559
4.

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Eckel F, Brunner T, Jelic S; ESMO Guidelines Working Group.

Ann Oncol. 2011 Sep;22 Suppl 6:vi40-4. doi: 10.1093/annonc/mdr375. No abstract available.

PMID:
21908502
5.

Pancreatic and hepatobiliary cancers.

Buck AK, Herrmann K, Eckel F, Beer AJ.

Methods Mol Biol. 2011;727:243-64. doi: 10.1007/978-1-61779-062-1_14.

PMID:
21331938
6.

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Eckel F, Brunner T, Jelic S; ESMO Guidelines Working Group.

Ann Oncol. 2010 May;21 Suppl 5:v65-9. doi: 10.1093/annonc/mdq167. No abstract available.

PMID:
20555105
7.

Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.

Eckel F, Herrmann K, Schmidt S, Hillerer C, Wieder HA, Krause BJ, Schuster T, Langer R, Wester HJ, Schmid RM, Schwaiger M, Buck AK.

J Nucl Med. 2009 Sep;50(9):1441-7. doi: 10.2967/jnumed.109.065896. Epub 2009 Aug 18.

8.

Biliary cancer: ESMO clinical recommendation for diagnosis, treatment and follow-up.

Eckel F, Jelic S; ESMO Guidelines Working Group.

Ann Oncol. 2009 May;20 Suppl 4:46-8. doi: 10.1093/annonc/mdp125. Review. No abstract available.

PMID:
19454460
9.

Argon plasma coagulation of cervical heterotopic gastric mucosa as an alternative treatment for globus sensations.

Bajbouj M, Becker V, Eckel F, Miehlke S, Pech O, Prinz C, Schmid RM, Meining A.

Gastroenterology. 2009 Aug;137(2):440-4. doi: 10.1053/j.gastro.2009.04.053. Epub 2009 May 4.

PMID:
19410576
10.

[Gastrointestinal oncology - therapy update 2008 / 2009].

Ebert MP, Auernhammer C, Caca K, Eckel F, Fischbach W, Geissler M, Göke B, Greten T, Kubicka S, Lutz MP, Möhler M, Opitz O, Pavel M, Porschen R, Reinacher-Schick A, Schmiegel W, Seufferlein T, Wiedenmann B, Schmid RM.

Z Gastroenterol. 2009 Mar;47(3):296-306. doi: 10.1055/s-2008-1027989. Epub 2009 Mar 6. Review. German.

PMID:
19267319
11.

Interleukin 1 beta gene promoter SNPs are associated with risk of pancreatic cancer.

Hamacher R, Diersch S, Scheibel M, Eckel F, Mayr M, Rad R, Bajbouj M, Schmid RM, Saur D, Schneider G.

Cytokine. 2009 May;46(2):182-6. doi: 10.1016/j.cyto.2009.01.005. Epub 2009 Feb 28.

PMID:
19251436
12.

In vivo characterization of proliferation for discriminating cancer from pancreatic pseudotumors.

Herrmann K, Eckel F, Schmidt S, Scheidhauer K, Krause BJ, Kleeff J, Schuster T, Wester HJ, Friess H, Schmid RM, Schwaiger M, Buck AK.

J Nucl Med. 2008 Sep;49(9):1437-44. doi: 10.2967/jnumed.108.052027. Epub 2008 Aug 14.

13.

Volume assessment in patients with necrotizing pancreatitis: a comparison of intrathoracic blood volume index, central venous pressure, and hematocrit, and their correlation to cardiac index and extravascular lung water index.

Huber W, Umgelter A, Reindl W, Franzen M, Schmidt C, von Delius S, Geisler F, Eckel F, Fritsch R, Siveke J, Henschel B, Schmid RM.

Crit Care Med. 2008 Aug;36(8):2348-54. doi: 10.1097/CCM.0b013e3181809928.

PMID:
18596637
14.

Capecitabine for treatment of advanced hepatocellular carcinoma.

von Delius S, Lersch C, Mayr M, Stock K, Schulte-Frohlinde E, Schmid RM, Eckel F.

Hepatogastroenterology. 2007 Dec;54(80):2310-4.

PMID:
18265654
15.

Emerging drugs for biliary cancer.

Eckel F, Schmid RM.

Expert Opin Emerg Drugs. 2007 Nov;12(4):571-89. Review.

PMID:
17979600
16.

Effect of low-molecular-weight heparin on survival in patients with advanced pancreatic adenocarcinoma.

von Delius S, Ayvaz M, Wagenpfeil S, Eckel F, Schmid RM, Lersch C.

Thromb Haemost. 2007 Aug;98(2):434-9.

PMID:
17721628
17.

Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis.

Schulte-Frohlinde E, Wagenpfeil S, Willis J, Lersch C, Eckel F, Schmid R, Schusdziarra V.

J Gastroenterol Hepatol. 2007 Aug;22(8):1241-8.

PMID:
17688664
18.

Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials.

Eckel F, Schmid RM.

Br J Cancer. 2007 Mar 26;96(6):896-902. Epub 2007 Feb 27.

19.

Pancreatic cancer: a review of recent advances.

Eckel F, Schneider G, Schmid RM.

Expert Opin Investig Drugs. 2006 Nov;15(11):1395-410. Review.

PMID:
17040199
20.

Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study.

von Delius S, Eckel F, Wagenpfeil S, Mayr M, Stock K, Kullmann F, Obermeier F, Erdmann J, Schmelz R, Quasthoff S, Adelsberger H, Bredenkamp R, Schmid RM, Lersch C.

Invest New Drugs. 2007 Apr;25(2):173-80. Epub 2006 Sep 13.

PMID:
16983507

Supplemental Content

Loading ...
Support Center